In situ laser fenestration during emergent thoracic endovascular aortic repair is an effective method for left subclavian artery revascularization  by Redlinger, Richard E. et al.
CLINICAL RESEARCH STUDIES
From the Southern Association for Vascular SurgeryFrom
Auth
Bu
Pres
tio
26
Rep
D
St
The
to
m
0741
Cop
httpIn situ laser fenestration during emergent thoracic
endovascular aortic repair is an effective method for
left subclavian artery revascularization
Richard E. Redlinger Jr, MD, Sadaf S. Ahanchi, MD, and Jean M. Panneton, MD, Norfolk, Va
Background: Retrograde laser fenestration of the left subclavian artery (LSA) during emergent thoracic endovascular
aortic repair (TEVAR) uses a relatively simple intraoperative method of endograft modiﬁcation to revascularize aortic
branches for a variety of acute thoracic aortic pathologies. This study presents our expanded experience and midterm
outcomes of TEVAR with laser fenestration to revascularize the LSA as an alternative to debranching.
Methods: Patients who underwent TEVAR with LSA revascularization by laser graft fenestration from September 2009
through August 2012 were retrospectively reviewed. TEVAR was performed with deployment of a Dacron (DuPont,
Wilmington, Del) endograft over the LSA oriﬁce. Laser catheter fenestration of the graft was performed through
retrograde brachial access, followed by balloon-expandable covered stent deployment through the fenestration to traverse
the endograft and LSA. Routine postoperative follow-up imaging with computed tomography angiography was per-
formed to assess TEVAR and LSA fenestration patency, endoleak, and aneurysm/dissection exclusion.
Results: TEVAR with laser fenestration was successfully performed in 22 patients (12 men; mean age, 57 years) in an
urgent or emergent setting secondary to unremitting symptoms or rupture. Twelve patients had large symptomatic
thoracic aortic aneurysms (eight secondary to chronic dissection); four patients had acute symptomatic type B aortic
dissection, and six patients had an intramural hematoma or penetrating aortic ulcer, or both. An average of two
endografts (range, 1-4) were deployed. LSA-covered stents were 8 to 10 mm in diameter. Mean operative time was 1546
65 minutes. Average hospital length of stay was 12 6 7 days. No major fenestration-related complications occurred. One
patient developed postoperative paraplegia. One patient died in the postoperative period, for an in-hospital mortality rate
of 4.5%. Two patients died of non-TEVAR-related causes at a mean follow-up of 10 months (range, 1-40 months).
Follow-up computed tomography angiography imaging demonstrated a 100% primary patency for the LSA stents. One
patient had an asymptomatic LSA stent stenosis. Type II endoleaks from the LSA in two patients required endovascular
coil embolization. No fenestration-related type I or III endoleaks were noted.
Conclusions: In situ retrograde laser fenestration is a feasible and effective option for LSA revascularization during
TEVAR involving a spectrum of acute thoracic aortic pathology. Laser fenestration provides a rapid, reproducible method
of fenestrating the endograft material. The high technical success, low fenestration-related morbidity, and excellent
midterm patency support this technique of intraoperative endograft modiﬁcation. (J Vasc Surg 2013;58:1171-7.)Acute thoracic aortic pathologies that encroach on
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(LSA). Conventional open thoracic aortic repair in an
urgent or emergent setting has been demonstrated to
have mortality rates close to 20% and signiﬁcant morbidity,
including a risk of spinal cord ischemia that can affect
18.6% of patients.1,2 Intentional endograft coverage of
the LSA was initially thought to be a viable alternative in
this setting to extend the applicability of TEVAR.3 Unfor-
tunately, expanding experience with intentional LSA
coverage without revascularization portends a signiﬁcantly
increased risk of subclavian steal syndrome, arm claudica-
tion, vertebral territory stroke, and spinal cord ischemia
by eliminating collateral blood supply to the spinal cord
from the vertebral artery.4,5
Several options have been described that allow patency
of the LSA to be maintained, including elective debranch-
ing before TEVAR, the chimney technique by deploying
an LSA stent parallel to the thoracic endograft,1171
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modiﬁed endografts.6-9 Yet the options in an urgent or
emergent setting are limited.
McWilliams et al10 initially used serial cutting balloons
as a modality for transluminal in situ fenestration of
a thoracic endograft after deliberate coverage of the LSA.
Subsequently, Murphy et al11 described a technique of in
situ laser graft fenestration of a Dacron (DuPont, Wilming-
ton, Del) endograft to revascularize an LSA during repair
of traumatic aortic transection in a young patient. We
have also reported our initial experience using retrograde
laser fenestration to revascularize the LSA during zone II
TEVAR.12 This relatively simple intraoperative method of
laser-mediated endograft modiﬁcation provides a rapid
and reproducible method of fenestrating the endograft
material to revascularize aortic branches for a variety of
acute thoracic aortic pathologies. Herein, we present our
expanded experience and midterm outcomes of TEVAR
with laser fenestration to revascularize the LSA as an alter-
native to an open repair or debranching procedure.
METHODS
This study was performed with approval of the Eastern
Virginia Medical School Institutional Review Board and
in compliance with the Health Insurance Portability and
Accountability Act.
Patient identiﬁcation. A retrospective review of the
electronic medical record was conducted to identify all
patients who had undergone TEVAR with in situ laser
fenestration to preserve ﬂow to the LSA from September
2009 through August 2012.
Laser fenestration technique. Thoracic endografts
were deployed using Talent or Valiant (Medtronic Inc,
Santa Rosa, Calif), TX2 (Cook Inc, Bloomington, Ind),
or TAG (W. L. Gore & Associates, Flagstaff, Ariz) stent
grafts. The laser fenestration was always created in
a proximal Dacron-based endograft. An 8F Lamp sheath
(St. Jude Medical, St. Paul, Minn), with a preformed angle
at the tip, was placed through retrograde left brachial artery
access at the ostium of the LSA. A 2.0- to 2.5-mm Turbo
Elite laser catheter (Spectranetics, Colorado Springs, Colo)
was placed at the ostium of the LSA perpendicular to the
endograft over a 0.018-inch Platinum Plus wire (Boston
Scientiﬁc, Natick, Mass; Fig 1).
The laser ﬁber was gently advanced to make contact
with the deployed Dacron endograft, followed by laser
energy application for 3 to 5 seconds to create the fenestra-
tion. The sheath and laser catheter were positioned before
stent graft deployment, and within minutes, the laser fenes-
tration was performed, limiting potential ischemia time
to <5 minutes in most cases. The 0.018-inch wire was
advanced through the laser catheter and fenestration into
the endograft lumen and exchanged for a stiff 0.035-inch
wire (Fig 2). The endograft fenestration was predilated
using a 6-mm balloon, followed by deployment of an
8- to 10-mm balloon-expandable iCAST covered stent
(Atrium, Hudson, NH). The stent was deployed app-
roximately one-quarter into the endograft lumen andthree-quarters into the branch vessel (Fig 3). The intra-
endograft portion of the covered stent was ﬂared using
a 14-  20-mm balloon introduced from the brachial
access. Finally, completion aortography was performed to
conﬁrm endograft and LSA fenestration patency without
endoleak.
Endograft and LSA fenestration imaging surveillance
with computed tomography angiography (CTA) was
performed before discharge and at regular intervals after
the procedure, typically at 1, 3, 6, and 12 months, to
assess patency, endoleak, and aneurysm and dissection
exclusion.
Outcome measures and analysis. The patients who
were identiﬁed all underwent TEVAR with LSA fenestra-
tion as described. Patient demographics, morphologic
presentation of aortic lesion, procedural information
and outcomes, complications, and follow-up data were
collected from the electronic medical record. Descriptive
statistics were used to describe patient data and outcomes
in this cohort.
RESULTS
Patient demographics and presentation. Our insti-
tutional experience using TEVAR with laser fenestration
was successfully performed in 22 patients (12 men) with
a mean age of 57 years (range, 37-83 years). All patients
underwent TEVAR with retrograde laser fenestration to
revascularize the LSA during TEVAR in an urgent or
emergent setting secondary to unremitting symptoms or
rupture on a compassionate-use basis. Every patient pre-
sented initially with symptoms of severe chest and/or
back pain on admission. Emergent cases were generally
performed within hours of patient presentation, whereas
the procedure in urgent cases varied in timing because
these patients underwent repair after an initial attempt at
medical management had failed and, ultimately, were
deemed to require urgent operative intervention.
Of the 22 study patients, 21 had hypertension, 15 had
a history of smoking, and seven had renal insufﬁciency,
deﬁned as serum creatinine >1.5 mg/dL (Table). Two
patients had Marfan syndrome, and two patients had
previous aortic root replacement. The indications for
TEVAR are shown in Fig 4. Twelve patients had large
symptomatic thoracic aortic aneurysms, of which eight
were secondary to chronic dissection (two type A and six
type B) and four were secondary to degenerative aneu-
rysms; four patients had acute symptomatic type B aortic
dissection, and six patients had intramural hematoma or
penetrating aortic ulcer, or both. Four patients had
evidence of aortic rupture, including one aneurysm
secondary to chronic dissection, one degenerative aneu-
rysm, one combined intramural hematoma and penetrating
aortic ulcer, and one acute type B aortic dissection. None
of the patients had dissection extending into the LSA.
Four patients had stenosis of the LSA. The mean maximal
aortic diameter was 52 mm (range, 28-90 mm).
Operative data. TEVAR was technically successful in
all 22 patients. An average of two endografts (range, 1-4)
Fig 2. The laser ﬁber is gently advanced to make contact with the
Dacron endograft, followed by laser energy application for 3 to 5
seconds to create the fenestration. An 0.018-inch wire is advanced
through the laser catheter and fenestration into the endograft
lumen and exchanged for a stiff 0.035-inch wire.
Fig 1. Left, The laser catheter is placed at the ostium of the left subclavian artery (LSA) perpendicular to the endograft
over a 0.018-inch wire. To create a clean, circular fenestration, the laser ﬁber should ideally be oriented at a 90 angle to
the endograft. Right, After laser activation, the laser catheter is advanced through the endograft.
Fig 3. The iCAST stent is deployed from the brachial access
approximately one-quarter into the endograft lumen and three-
quarters into the branch vessel.
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placed in 18 patients: Medtronic endografts were solely
used in 12 patients, Cook TX2 devices were solely used in
one patient, a Medtronic Talent endograft was placed
proximally with a Cook TX2 distally in one patient, and
a combination of Talent endografts were placed proximally
with a Gore TAG placed distally in two patients. The graft
through which the fenestration was created was a Med-
tronic Talent or Valiant endograft in 19 of the 22 patients,whereas the fenestrated graft was a Cook TX2 in the
remaining three patients.
A zone II deployment within the aortic arch was used
in 19 patients. A zone I TEVAR deployment was used in
one patient who had previously undergone a left common
carotid transposition. Two patients with chronic type A
aortic dissection underwent TEVAR with zone 0 deploy-
ment. The ﬁrst patient had Marfan syndrome and had
initially undergone an aortic root and arch replacement
with innominate and left common carotid bypass grafting.
The second patient had a previous aortic root replacement
secondary to the type A dissection and a bovine arch
anomaly that required zone 0 deployment with in situ
LSA fenestration and also a back-table surgeon-modiﬁed
graft fenestration for the innominate artery, achieving
a totally endovascular fenestrated arch replacement for
Table. Demographics and comorbid conditions in
patients undergoing thoracic endovascular aortic repair
(TEVAR) with in situ retrograde laser fenestration
Variable
Mean (range) or
percentage (n ¼ 22)
Male sex 54.5
Black race 59
Age, years 57 (37-83)
Comorbid conditions
Hypertension 95.5
Smoking 68.2
Dyslipidemia 40.9
Renal insufﬁciency 31.8
Congestive heart failure 27.3
Chronic obstructive pulmonary disease 27.3
Diabetes mellitus 18.2
Coronary artery disease 18.2
Peripheral arterial disease 9.1
Arrhythmia 4.5
Fig 4. The etiology of presentation of the 22 patients undergoing
thoracic endovascular aortic repair (TEVAR) with in situ retro-
grade laser fenestration. IMH, Intramural hematoma; PAU,
penetrating aortic ulcer.
Fig 5. Left subclavian artery (LSA) stent patency, without
evidence of endoleak and stable aortic size are demonstrated on
39-month follow-up (left) computed tomography angiography
and a (right) volume-rendered image.
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raft fenestration was performed to accommodate place-
ment of a covered stent into a 16-mm innominate artery.
This stent size exceeds the maximum diameter of stent
that should be placed through a 3-mm laser endograft
fenestration. This patient had been turned down for open
arch replacement by cardiothoracic surgery.
The left brachial artery was accessed percutaneously in
eight patients, with open left brachial exposure required in
the remaining patients. LSA-covered stents ranged in diam-
eter from 8 to 10 mm. Mean operative time for TEVAR
with laser fenestration was 154 6 65 minutes, and the
mean contrast volume was 134 6 64 mL. An average of
20 minutes of the total case time was required for obtain-
ing brachial access, fenestration of the graft, and LSA stent
deployment.
Perioperative outcomes and complications. No
major in situ laser fenestration-related operative complica-
tions occurred, but two minor access-related complications
were noted. These two patients required early post-
operative reintervention. One patient required exploration
and repair of a left brachial artery after percutaneous access
for LSA fenestration and stent deployment. A second
patient, who had open left brachial access, required evac-
uation of a groin and left arm hematoma. TEVAR-related
complications included one patient (4.5%) who devel-
oped postoperative paraplegia after emergent repair for
a ruptured acute aortic dissection. One patient with Marfan
syndrome underwent aortic root replacement 15 days after
TEVAR for a retrograde aortic dissection caused by the
proximal bare stent of a Talent endograft that was landed
proximal to the left common carotid artery. This patient
recovered uneventfully.
There were no perioperative strokes, transient ischemic
attacks, or other neurologic complications. One patient
died, resulting in an in-hospital mortality rate of 4.5%.
This patient initially presented with massive hemoptysisfrom an aortobronchial ﬁstula, suffered recurrent hemop-
tysis, and ultimately died of severe pneumonia in the post-
operative period. The average hospital length of stay was
12 6 7 days (range, 3-30 days).
Midterm follow-up. At a mean follow-up of 11
months (range, 1-40 months), there was 100% primary
patency for the LSA stents, as demonstrated by routine
follow-up CTA imaging. A representative image is
demonstrated in Fig 5. One patient had an asymptomatic
LSA stent stenosis. Two patients had type II endoleaks
from the LSA that required reintervention. Both patients
underwent successful reintervention with endovascular coil
embolization through a combined percutaneous femoral
and brachial artery access. Endoleak obliteration was
conﬁrmed with completion angiography and follow-up
CTA. There were no fenestration-related type I or III
endoleaks. None of the patients with retrograde LSA
fenestration have reported left arm claudication symptoms
or vertebral basilar symptoms at the follow-up examination.
Two patients (9%) had died of non-TEVAR-related causes:
the ﬁrst, with previous dialysis-dependent renal failure, died
JOURNAL OF VASCULAR SURGERY
Volume 58, Number 5 Redlinger et al 1175of renal failure 4 months after repair, and the second died
of a traumatic fall 14 months after TEVAR.
DISCUSSION
Intentional coverage of the LSA during TEVAR has
been performed routinely by some and is thought to be
associated with a low risk of clinically signiﬁcant sequelae.13
However, increased experience with this technique has
resulted in growing evidence that LSA coverage is accom-
panied by a recognized risk of arm claudication, vertebral
territory and anterior circulation stroke, and spinal cord
ischemia, which can necessitate interval carotid-to-
subclavian bypass to alleviate symptoms.14 In 2009, these
ﬁndings ultimately led to the Society for Vascular Surgery
Committee on Aortic Disease to suggest routine preopera-
tive revascularization for planned coverage of the LSA
during elective TEVAR and additionally strongly recom-
mended routine revascularization in circumstances where
collateral perfusion might be compromised.15 These prac-
tice guidelines did make exceptions in the setting of emer-
gent TEVAR or when other circumstances would preclude
preoperative LSA revascularization.15 Routine revasculari-
zation is still controversial, because studies also exist that
challenge its absolute necessity. Maldonado et al16 recently
described their experience and concluded that LSA
coverage does not result in an increased incidence of spinal
cord ischemia or stroke when a selective LSA revasculariza-
tion strategy is adopted. They found similar outcomes
among noncovered, covered, and covered and revascular-
ized LSAs. However, they did acknowledge that the exact
individual criterion on which the decision between
covering and revascularizing the LSA was made was not
abundantly clear.
Alternatives to LSA coverage that allow for attaining an
adequate proximal seal for thoracic endografting include
elective bypass to or transposition of the LSA or deploy-
ment of scalloped and branched grafts.17,18 Open LSA
revascularization often requires longer operative times
and the need for multiple surgical interventions with staged
endografting. Open revascularization also has potential
risks for vocal cord paralysis and injury to the thoracic
duct, brachial plexus, and phrenic nerve. Prefabricated,
patient-customized devices, which require extensive plan-
ning with precise preoperative imaging and time for graft
manufacturing, are not commercially available in the
United States currently. For this reason, these modalities
are often not advisable or feasible for patients presenting
with the acute thoracic aortic pathologies as described in
this case series.
Our early experience with back-table testing revealed
that the laser created a clean fenestration of the Dacron
material while maintaining the overall endograft integrity.
This led to our continued interest in using this technique
in emergent situations complicated by the need to obtain
an adequate proximal seal without compromising the
LSA.12 This technique offers a relatively simple, in vivo
method of endograft modiﬁcation that can be applied in
a variety of acute thoracic aortic pathologies. Furthermore,the laser provides a rapid and reproducible method of fen-
estrating the endograft material.
Our experience has found the preoperative CT scan
to be predictive of success and very helpful with preopera-
tive planning for in situ fenestration. Ideally, a three-
dimensional reconstruction of the CT scan would be
helpful, but the patients in this series underwent urgent
operations, and time for this was not always available.
Coronal and sagittal views allow for visualization of the
arch anatomy and location of the vertebral artery takeoff
from the LSA and for planning the orientation of the laser
ﬁber. We do not routinely obtain preoperative intracranial
imaging but attempt to revascularize the LSA in most
urgent or emergent cases due to the increased risk of tran-
sient hypotension and concerns for spinal cord ischemia
and stroke in these patients. Carotid duplex ultrasound
imaging to determine patency or dominance of the verte-
bral arteries could be obtained preoperatively in some
patients.
In our experience, we elect to cover the LSA without
revascularization in certain emergent situations such as
traumatic transection or in patients who require a short
length of aortic coverage during TEVAR. The distance
between the common carotid artery and LSA was 5 to
16 mm on preoperative CT scan in this series of patients.
Our proximal endograft is usually deployed immediately
distal to the left common carotid artery, so based on
our experience, the fenestrations should be attempted if
>5 mm is available between the proximal endograft fabric
and the LSA. Special attention must be paid to anatomic
considerations in this technique. The judicious use of
multiple C-arm projections before laser fenestrations
ensures that the laser ﬁber is aligned appropriately with
the endograft.
Among other technical considerations is the use of pre-
formed angled brachial sheaths, including newer articulat-
ing devices. We have come to fenestrate more frequently
with Medtronic endografts because of the greater distance
between stent struts in which to create the fenestration.
Cook TX2 devices have a smaller area of fabric between
stent struts, and for this reason, the maximum diameter
for the LSA covered stent we will use is no more than
8 mm to prevent pushing the struts apart. On bench
testing, we have found that the laser simply deﬂects off
the strut. Regardless of the proximal endograft design,
however, we do not orient the stent struts and the LSA
during TEVAR deployment; instead, we focus on accu-
rately landing our proximal fabric immediately distal to
the left common carotid artery and allow the laser to ﬁnd
the nearest fabric during laser fenestration.
The angle of the LSA takeoff from the aortic arch has
a substantial effect on the technical ease and success of laser
fenestration. This clinical scenario accounts for the single
aborted attempt at laser fenestration reported in our initial
series of patients.12 This attempt was aborted before activa-
tion of the laser secondary to the intraoperative ﬁnding of
an acute takeoff angle of the LSA in a type III aortic arch.
The covered LSA in this instance was revascularized instead
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a clean, circular fenestration, the laser ﬁber ideally must
be oriented at a 90 angle to the endograft, as demon-
strated in Fig 1, and an angle that is too acute (<30)
will not allow the fenestration to be created. When this
anatomic scenario is encountered, in situ laser fenestration
should not be performed. Other criteria that preclude the
use of this technique are also based on unfavorable
anatomic criteria, including subclavian origin dilatation
>12 mm, which exceeds the size of the largest available
iCAST covered stents and would compromise seal, a low
vertebral artery takeoff not allowing for an appropriate
landing zone for the covered stent, and involvement of
the LSA by dissection or aneurysmal disease.
We recognize that the current practice of endograft
modiﬁcation is controversial. Increasing experience with
endovascular management of vascular pathology has led
to efforts to broaden the indications for use of these tech-
niques. The patients in this series underwent TEVAR with
retrograde laser fenestration to revascularize the LSA on
a compassionate-use basis in an urgent or emergent setting
secondary to unremitting symptoms or ﬁndings of aortic
rupture. A United States Food and Drug Administration-
approved investigational device exemption was not ob-
tained before use of this technique at our institution.
However, every patient was made aware of the off-label
modiﬁcation of the endograft that was required for his or
her operation. This was part of a detailed discussion of risks
and beneﬁts of the technique while obtaining informed
consent for the procedure.
This case series suggests that promising midterm results
can be achieved after TEVAR with LSA revascularization
by laser graft fenestration in patients presenting with
various acute aortic pathologies. We report satisfactory
durability and acceptable reintervention and complication
rates. The observed perioperative morbidity and mortality
after the technique of retrograde in vivo laser fenestration
compare favorably with other techniques of LSA revascu-
larization. The average hospital length of stay of 12 6 7
days was variable within the cohort, as noted by the large
standard deviation. The four patients who presented with
aortic rupture had more complicated postoperative courses,
with an average length of stay of 23 days, and these patients
contributed greatly to prolong the average in-hospital
length of stay.
As with any endovascular procedure, strict surveillance
of these endografts and modiﬁcations will be necessary to
ensure durability of repair. The long-term interactions
between the endograft and the covered stent will need to
be monitored closely over time because of the potential
for stent collapse or stent breakage and the development
of a late type III endoleak between the two components.
Our future work in regard to these concerns will address
microscopic alterations to endograft fabrics after laser
fenestration. Until further technologic advances and clin-
ical trials lead to the approval of branched arch devices,
this technique offers a safe and feasible option to revascu-
larize the LSA during TEVAR. Longer follow-up remainsnecessary to better elucidate the fenestrated stent graft
and the LSA covered stent interactions, as well as, the dura-
bility of this technique.
CONCLUSIONS
The technique of in situ retrograde laser fenestration
is a feasible and effective option for LSA revascularization
during emergent TEVAR involving a spectrum of acute
thoracic aortic pathologies. Laser fenestration provides
a rapid and reproducible method of fenestrating the endog-
raft material. The high technical success, low fenestration-
related morbidity, and excellent midterm patency support
this technique of intraoperative endograft modiﬁcation in
the absence of available branched devices for arch deploy-
ment. Longer follow-up remains necessary to determine
the durability of this technique.
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